Development and validation of bile acid profile-based scoring system for identification of biliary atresia: a prospective study
Background: Early distinguishing biliary atresia from other causes of infantile cholestasis remains a major challenge. We aimed to develop and validate a scoring system based on bile acid for identification of biliary atresia.
Methods: In a prospective study, a total of 141 infants with cholestasis were enrolled in two sets (derivation cohort, n=66; validation cohort, n=75) from 2014 to 2018. Variables with significant difference between biliary atresia and non-biliary atresia infants were selected in the derivation cohort. Then, a scoring system including those variables was designed and validated.
Results: Among 66 patients in the derivation cohort, 34 (51.5%) had biliary atresia. A scoring system was proposed with the following variables: glycochenodeoxycholic acid/chenodeoxycholic acid, clay stool, and gamma-glutamyl transferase. The total score ranged from 0 to 41, and a cutoff value of 15 identified biliary atresia with an area under receiver operating characteristic curve of 0.87 (95% confidence interval, 0.77–0.94), sensitivity of 85.3%, and specificity of 81.3% in the derivation cohort; these values were also confirmed in a validation cohort with a sensitivity of 90.0% and specificity of 80.0%.
Conclusions: The proposed simple scoring system had good diagnostic accuracy for estimating the risk of biliary atresia in infants with cholestasis.
Figure 1
Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Posted 16 May, 2020
On 13 Feb, 2020
On 27 Apr, 2020
Received 25 Apr, 2020
Received 21 Apr, 2020
On 08 Apr, 2020
On 06 Apr, 2020
Invitations sent on 06 Apr, 2020
On 06 Apr, 2020
On 05 Apr, 2020
On 31 Mar, 2020
On 03 Mar, 2020
Received 01 Mar, 2020
Received 01 Mar, 2020
On 16 Feb, 2020
On 15 Feb, 2020
On 14 Feb, 2020
On 14 Feb, 2020
Invitations sent on 14 Feb, 2020
On 13 Feb, 2020
On 10 Feb, 2020
Development and validation of bile acid profile-based scoring system for identification of biliary atresia: a prospective study
Posted 16 May, 2020
On 13 Feb, 2020
On 27 Apr, 2020
Received 25 Apr, 2020
Received 21 Apr, 2020
On 08 Apr, 2020
On 06 Apr, 2020
Invitations sent on 06 Apr, 2020
On 06 Apr, 2020
On 05 Apr, 2020
On 31 Mar, 2020
On 03 Mar, 2020
Received 01 Mar, 2020
Received 01 Mar, 2020
On 16 Feb, 2020
On 15 Feb, 2020
On 14 Feb, 2020
On 14 Feb, 2020
Invitations sent on 14 Feb, 2020
On 13 Feb, 2020
On 10 Feb, 2020
Background: Early distinguishing biliary atresia from other causes of infantile cholestasis remains a major challenge. We aimed to develop and validate a scoring system based on bile acid for identification of biliary atresia.
Methods: In a prospective study, a total of 141 infants with cholestasis were enrolled in two sets (derivation cohort, n=66; validation cohort, n=75) from 2014 to 2018. Variables with significant difference between biliary atresia and non-biliary atresia infants were selected in the derivation cohort. Then, a scoring system including those variables was designed and validated.
Results: Among 66 patients in the derivation cohort, 34 (51.5%) had biliary atresia. A scoring system was proposed with the following variables: glycochenodeoxycholic acid/chenodeoxycholic acid, clay stool, and gamma-glutamyl transferase. The total score ranged from 0 to 41, and a cutoff value of 15 identified biliary atresia with an area under receiver operating characteristic curve of 0.87 (95% confidence interval, 0.77–0.94), sensitivity of 85.3%, and specificity of 81.3% in the derivation cohort; these values were also confirmed in a validation cohort with a sensitivity of 90.0% and specificity of 80.0%.
Conclusions: The proposed simple scoring system had good diagnostic accuracy for estimating the risk of biliary atresia in infants with cholestasis.
Figure 1
Figure 2